Copyright
©The Author(s) 2018.
World J Clin Oncol. Apr 10, 2018; 9(2): 26-32
Published online Apr 10, 2018. doi: 10.5306/wjco.v9.i2.26
Published online Apr 10, 2018. doi: 10.5306/wjco.v9.i2.26
Figure 2 Summary of the literature data on cfDI determination in primary breast cancer vs healthy females.
1Note that cfDI by β-actin was evaluated as difference between large and short amplicons and not as ratio longer to shorter amplicons. BC: Breast cancer; MBC: Metastatic breast cancer.
- Citation: Sobhani N, Generali D, Zanconati F, Bortul M, Scaggiante B. Cell-free DNA integrity for the monitoring of breast cancer: Future perspectives? World J Clin Oncol 2018; 9(2): 26-32
- URL: https://www.wjgnet.com/2218-4333/full/v9/i2/26.htm
- DOI: https://dx.doi.org/10.5306/wjco.v9.i2.26